MCL1 and metabolic disease: In addition to a possible application of EAT gene transfer to treatment and prevention of obesity and obesity-associated metabolic diseases, our data also show that overexpression of the EAT gene with three repeated injections at three different doses did not lead to aberrant histological changes in major organs and adipose tissues.